Results

Total Results: 3,096 records

Showing results for "drug".

401. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=452
     January 01, 2024 - Healthcare-Associated Infections (HAIs), Adverse Events, Hospitals Feinstein J , Dai D , Zhong W Potential drug-drug … This study assessed the prevalence and characteristics of potential drug-drug interactions (PDDI) among … One-half of all these exposures were due to less common specific drug pairs (3 percent of patients exposed … Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.

402. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=359
     January 01, 2024 - McManus KA , Rodney RC , Rhodes A Affordable Care Act qualified health plan enrollment for AIDS Drug … It used the Virginia AIDS Drug Assistance Program ACA implementation to illustrate one program's shift … Affordable Care Act qualified health plan enrollment for AIDS Drug Assistance Program clients: Virginia's … The authors studied the prevalence of common drug allergies and patient characteristics documented in … Drug allergies documented in electronic health records of a large healthcare system.

403. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=201
     January 01, 2024 - , Reese T , Decker S Implementation of clinical decision support services to detect potential drug-drug … The authors report on the implementation and evaluation of CDS Services which represent potential drug-drug … Implementation of clinical decision support services to detect potential drug-drug interaction using … Keywords: Clinical Decision Support (CDS), Adverse Drug Events (ADE), Medication, Adverse Events, Patient … Keywords: Adverse Drug Events (ADE), Medication, Medical Errors, Adverse Events, Data, Patient Safety

404. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=382
     January 01, 2024 - Drug Alcohol Depend 2016 Apr 1;161:206-13. doi: 10.1016/j.drugalcdep.2016.02.004. . … Keywords: Adverse Drug Events (ADE), Electronic Prescribing (E-Prescribing), Medication: Safety, Medical … This paper evaluated rates of potential look-alike sound-alike (LA-SA) drug errors in the drug management … The authors found no statistically significant change in error rate for each of the 11 drug pairs studied … Keywords: Adverse Drug Events (ADE), Medication, Medication: Safety, Medical Errors, Patient Safety

405. 2012 Updated Recommendations for Treating Rheumatoid Arthritis | Agency for Healthcare Research and Quality
     www.ahrq.gov/chain/practice-tools/practice-guidelines/2012-updated-recommendations-for-treating-rheumatoid-arthritis.html
     March 01, 2017 - Food and Drug Administration approval of new biologic agents and the emergence of research evidence regarding

406. What Happens After a Patient Safety Event? Medical Expenditures and Outcomes in Medicare (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Encinosa.pdf
     January 01, 2003 - Methods: We used inpatient, outpatient, and drug claims data for elderly Medicare enrollees with secondary … events using 247 adverse drug events in 207 hospitalized patients in 2 hospitals in Boston over a 7 … Outpatient and drug payment means are conditional upon not dying. … in any extra outpatient drug payments. … The costs of adverse drug events in hospitalized patients. JAMA 1997;277(4):307–11. 5.

407. New AHRQ Views Blog Posts: AHRQ at AcademyHealth’s 2018 Annual Research Meeting | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/620.html
     June 01, 2018 - Study Finds Medicare Advantage Enrollees Have Lower Health Risks Based on Their Prescription Drug Use … Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients … Study Finds Medicare Advantage Enrollees Have Lower Health Risks Based on Their Prescription Drug Use … The article, in  Health Services Research , analyzed drug use patterns for Medicare beneficiaries to

408. Final Progress Report: Unexpected Clinical Events: Impact on Patient Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-12/weinger2-report.pdf
     January 01, 2024 - Required controlled ventilation until drug effect gone. 4 Hypotension with induction. … Drug concentration was double what was intended. … Task Analysis of the Drug and Fluid Administration Process. … Drug preparation far outweighed drug administration tasks. … Task Analysis of the Drug and Fluid Administration Process.

409. Using the AHRQ Pharmacy Survey on Patient Safety Culture (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/pharmacy/pharmwebinar/cousins_introslides.pdf
     October 29, 2013 - (2011) National Association of Chain Drug Stores (NACDS) 2011-2012 Chain Pharmacy Industry Profile … Nicholson National Assoc of Chain Drug Stores Laura Pizzi Jefferson University Rebecca P.

410. Scientific Rationale | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-rationale.html
     September 01, 2013 - multicenter studies, which have supported its ability to reduce environmental contamination due to multi-drug … Effectiveness of Decolonization with Mupirocin and Chlorhexidine Mupirocin is a prescription drug that … was approved by the Food and Drug Administration (FDA) in 2002 for topical treatment of mild wounds

411. Dentists Prescribing Fewer High-Alert Drugs to Children | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/850.html
     February 01, 2023 - decreased from 2012 to 2019, according to an AHRQ-funded study published in Pharmacoepidemiology and Drug

412. AHRQ’s National Advisory Council Identifies Priority Areas for Quality Improvement | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/844.html
     December 01, 2022 - Evidence has shown that Food and Drug Administration-approved medications are effective treatments for … Shared decision-making for drug-drug interactions: formative evaluation of an anticoagulant drug interaction

413. Best Practices in Medication Safety: Areas for Improvement in the Primary Care Physician’s Office (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Galt.pdf
     April 23, 2004 - their access to drug information sources. … Drug sample inventory was primarily managed by pharmaceutical representatives. … current and accurate list optimizes prescribing through proactive screening for potential allergies, drug-drug … interactions or drug-disease interactions. … More clinics ban drug samples, citing cost, safety concerns.

414. Standardized infection ratios for central line-associated bloodstream infections and surgical site infections, 2009–2012
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/qdr2015-ptschartbook.pptx
     March 04, 2016 - Adverse drug events (41.4 per 1,000 hospital discharges) accounted for 34.2% of total HACs and pressure … During that same period, adverse drug events decreased from a rate of 49.5 per 1,000 discharges (more … from medical intervention involving a drug. … Medication errors do not include adverse drug reactions. … Recent studies have shown antipsychotic use is also a drug safety issue (Huybrechts, et al., 2012).

415. Appendix 3: Data Abstraction (xls file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-appendix3-data-abstraction.xlsx
     June 24, 2022 - Innovative Medicine Fund (UK) 14 National Insitute for Health and Care Excellence (NICE) Cancer Drug … Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-32. doi: 10.1002/pds.4295. PMID: 28913963. … and Biological Products Guidance for Industry US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … and Biological Products US Food & Drug Administration.

416. Final Progress Report: The elderly and OTC labeling information: A randomized controlled experiment test (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/16801-Sangasubana-draft-1.pdf
     February 28, 2010 - product; (2) to determine the sources of drug information they would use to find out more about an … risk perceptions of OTC products SCOPE Background: Currently, there is a trend by the US Food and Drug … is the largest group that uses prescription and OTC medicines, and the group is more vulnerable to drug … examined how the elderly (those who are 65 or older) evaluated risk in using OTC drugs and utilized drug … There were also insufficient data to determine the sources of drug information the elderly would use

417. Final Progress Report: Electronic Communications Across Provider Settings (pdf file)
     www.ahrq.gov/sites/default/files/2024-07/morrison-report.pdf
     January 01, 2024 - Finally, a plan for measuring adverse drug events was created. … Medications are updated and drug interaction checking is done from the patient’s home. … ability to capture coded medications at the time of visit, produce electronic prescriptions, and perform drug … Jones for hyperlipidemia and is on a statin drug. … The report would look to see if he presented with symptoms of drug induced hepatitis (jaundice, etc.

418. Technical Specifications and Chart Abstraction Tool (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-tech-specs.pdf
     December 14, 2011 - sickle cell disease. 1: The addition of or an increase in a continuous infusion of any cardioactive drug … disease, unstable shock (the addition of or an increase in a continuous infusion of any cardioactive drug … : Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug … : Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug … "Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug

419. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/evidence-based-reports/search.html?page=23
     July 01, 2012 - Type: Comparative Effectiveness Reviews Affiliation: Minnesota EPC Report Status: Final Drug … Comparative Effectiveness Reviews Affiliation: Johns Hopkins University Report Status: Final Drug

420. Standardizing Medication Error Event Reporting in the U.S. Department of Defense (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Nosek.pdf
     March 01, 2004 - pharmaceuticals.1–3 Health care professionals are encouraged to report medication errors and adverse drug … Food and Drug Administration (FDA) and the Medication Error Reporting (MER) program coordinated by … Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274(1):35–43. 3. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … USP launches MEDMARX as the third major national reporting program for adverse drug events; 1998.